ZQP-11154-08454
3 vaccinations
7 coded responses
26 check-ins
7 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 193 / PA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Registered in v-safe
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2020-12-31
Survey response — days 1–6 daily, dose 1MedDRA: Injection site urticaria — Feeling: Good · Site: Redness, ItchingFree text: Hives around injection site x 3 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-01
- 2021-01-02
-
2021-01-03
Survey response — days 1–6 daily, dose 1MedDRA: Injection site reaction, Urticaria — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Significant welts at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-03
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-04
Survey response — day 7, dose 1MedDRA: Injection site pain, Neuralgia, Pain in extremity, Unevaluable event — Feeling: Good · Site: Pain · Joint pains · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Shingles like pain at injection site and down arm · Healthcare visit (other): Need to be seen my allergy doctor before getting second doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Report sent to call center — day 7, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-11
Survey response — day 14, dose 1MedDRA: Paraesthesia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Paresthesias to extremitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-18
-
2021-01-25
Dose 2 — Pfizer-BioNTech
-
2021-01-25
Health check-in — day 0, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-27
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Site: RednessFree text: Dizziness x 1 hourMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-30
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Itching · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-01
- 2021-02-02
-
2021-02-05
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-04-26
-
2021-07-26
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous, Complement deficiency disease — Feeling: GoodFree text: Complement deficiency MiscarriageMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-11
Dose 3 — Pfizer-BioNTech
-
2022-01-25
Survey response — 12 months, dose 2MedDRA: Complement deficiency disease — Feeling: GoodFree text: Complement deficiencyMedDRA releases: 2024-11 · check-in free text available
- 2022-10-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-25 | Pfizer-BioNTech | |
| 3 | 2021-10-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-03 | Successful | Reported to VAERS voluntarily prior to GDIT contact |
| 2021-01-04 | Successful | Reported to VAERS voluntarily prior to GDIT contact |
| 2021-01-11 | Successful 2021-02-05 |
Reported to VAERS voluntarily prior to GDIT contact |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Hives around injection site x 3 days
Systemic reaction (other): Significant welts at injection site
Release 1 — day 7, dose 1
Systemic reaction (other): Shingles like pain at injection site and down arm
Healthcare visit (other): Need to be seen my allergy doctor before getting second dose
Release 1 — day 14, dose 1
Symptoms: Paresthesias to extremities
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness x 1 hour
Release 9 — 6 months, dose 2
Symptoms: Complement deficiency Miscarriage
Release 11 — 12 months, dose 2
Symptoms: Complement deficiency
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Abortion spontaneous | ✓ | · | ✓ |
| SD | Complement deficiency disease | ✓ | · | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
| SRO | Injection site urticaria | ✓ | ✓ | ✓ |
| SRO | Neuralgia | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release